WILLIAM A PULLEN
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism SANTA MONICA, CA NPI 1104977248
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism CA ABBVIE INC. All categories
General Payments — all program years on this page
$4,593.47
- Category: General Payments
- Program years: PY2018–2024
- Record count: 171
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $220.07 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $220.07 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $103.85 | 4 |
| Abbott Laboratories | $28.31 | 1 |
| PFIZER INC. | $25.93 | 1 |
| Gilead Sciences, Inc. | $22.46 | 1 |
| Amgen Inc. | $22.35 | 1 |
| Acerta Pharma LLC | $17.17 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1105324679 | ABBVIE INC. | $30.71 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105324683 | ABBVIE INC. | $22.56 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105324687 | ABBVIE INC. | $25.50 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105324691 | ABBVIE INC. | $25.08 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105492847 | AstraZeneca Pharmaceuticals LP | $17.17 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116031677 | Amgen Inc. | $22.35 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124849442 | Abbott Laboratories | $28.31 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131089135 | PFIZER INC. | $25.93 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133770555 | Gilead Sciences, Inc. | $22.46 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.